跳至主要内容
临床试验/NCT07592897
NCT07592897尚未招募4 期

Efficacy of Vitamin B Complex in the Recovery of Inferior Alveolar Nerve Paresthesia: A Randomized Clinical Trial

University of Sao Paulo0 个研究点目标入组 50 人开始时间: 2026年6月10日最近更新:

试验速览

阶段
4 期
状态
尚未招募
入组人数
50

研究概览

简要总结

Why is this study being done? Paresthesia is a change in sensation that can cause numbness, tingling, or loss of feeling in a part of the body. This condition can occur after dental procedures such as wisdom tooth (third molar) extraction, dental implant placement, or jaw surgery. When this happens, the inferior alveolar nerve - which is responsible for sensation in the lower lip, chin, and gum area on the side of the jaw - may be injured. This can affect a person's quality of life, making everyday activities like eating, drinking, speaking, and even smiling feel different or uncomfortable.

What is being studied? This study is testing whether taking B vitamins (vitamin B complex) can help the inferior alveolar nerve recover faster and more completely compared to a placebo (an inactive pill that looks the same but contains no active medicine). B vitamins - especially B1 (thiamine), B6 (pyridoxine), and B12 (cyanocobalamin) - are known to play important roles in nerve health, including helping repair damaged nerves and maintaining the protective covering around nerves called myelin.

Who can participate? Adults between 18 and 70 years old who have numbness or altered sensation in the lower lip, chin, or gum area caused by damage to the inferior alveolar nerve following a dental procedure (specifically wisdom tooth extraction), and whose symptoms began between 7 and 30 days ago.

What will happen in the study?

Participants will be randomly assigned (like flipping a coin) to one of two groups:

Vitamin B complex group: Takes one capsule daily containing B vitamins

Placebo group: Takes one identical-looking capsule daily with no active ingredients

Neither the participants nor the doctors performing the sensory tests will know which group they are in. This is called a "blinded" study and helps ensure the results are reliable.

Participants will attend 6 scheduled visits over 8 weeks:

T0 (baseline): Initial sensory testing, questionnaires, and receiving the study medication

T1 (1 week): Follow-up sensory testing

T2 (2 weeks): Follow-up sensory testing

T3 (4 weeks): Follow-up sensory testing

T4 (6 weeks): Follow-up sensory testing

T5 (8 weeks): Final sensory testing and end of study participation

At each visit, researchers will perform simple, non-invasive tests to measure sensation in the affected area, including:

Light touch tests with soft nylon filaments (monofilaments)

Two-point discrimination (testing the ability to feel one or two points touching the skin)

Pinprick sensation (testing sharp touch)

Temperature sensation (warm and cold)

Visual Analog Scale (VAS) where participants rate their sensation on a scale

What are the possible benefits? Participants who receive the vitamin B complex may experience faster or more complete recovery of sensation in their lower lip, chin, or gum area. Even those in the placebo group may experience some improvement due to the body's natural healing process. All participants will receive close monitoring of their nerve function over 8 weeks.

What are the possible risks? The risks are considered low. B vitamins are generally safe at the doses used in this study. Some people may experience mild side effects such as nausea or stomach discomfort. Rarely, allergic reactions may occur. The sensory tests may cause mild, temporary discomfort but no pain. If any side effects occur, the study medication will be stopped and appropriate care will be provided.

Is participation voluntary? Yes. Participants can withdraw from the study at any time without any impact on their regular dental or medical care.

Where will the study take place? The study will be conducted at the Faculdade de Odontologia da Universidade de São Paulo (FOUSP) and the Fundação para o Desenvolvimento da Odontologia (FUNDECTO).

详细描述

Detailed Description

Study Design Overview

This is a single-center, parallel-group, superiority, randomized, double-blind, placebo-controlled clinical trial designed to evaluate the efficacy of vitamin B complex supplementation in promoting sensory recovery among patients with paresthesia of the inferior alveolar nerve (IAN) following mandibular third molar extraction. The study adopts an experimental, longitudinal design with repeated measures at six time points over an eight-week follow-up period.

The trial will be conducted at the Faculdade de Odontologia da Universidade de São Paulo (FOUSP) and at the Fundação para o Desenvolvimento da Odontologia (FUNDECTO), both located in São Paulo, Brazil. Enrollment is expected to occur consecutively based on patient referrals and spontaneous demand from the dental surgery outpatient clinics. The total planned sample size is 50 participants, determined dynamically based on clinical availability but powered to detect clinically meaningful differences between groups based on prior literature.

Study Setting and Recruitment

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)

盲法说明

This is a double-blind study. The following parties are masked to group assignment (vitamin B complex vs. placebo):

Participants: Unaware of which capsule they receive (active or placebo).

Outcome Assessors: Clinicians performing all sensory tests (monofilaments, two-point discrimination, pinprick, thermal) are blinded.

Principal Investigator (during data collection): Unaware of treatment allocation while participants are actively enrolled and undergoing follow-up.

Data Analyst / Statistician: Remains blinded until database lock and final analysis. A blinded sample size re-estimation will be performed after the pilot phase, during which the statistician will only observe pooled variance without group identifiers.

Study Coordinator (during visits): May interact with participants but does not have access to the randomization list or medication kit contents.

Only one individual (Pharmacy Custodian) is unblinded. This person:

Generates the randomization sequence.

Prepares and label

入排标准

年龄范围
18 Years 至 70 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Clinical diagnosis of mandibular neurossensorial disturbances.
  • Must be able to swallow tablets

排除标准

  • - Any known allergy to complex B supplementation or its components.

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Ricardo Grillo

Assistant Professor

University of Sao Paulo

相似试验